Change in fracture risk and fracture pattern after bariatric surgery: Nested case-control study

BMJ (Online)

Volumn 354, Issue , 2016, Pages

  Rousseau, Catherine ^a,b   Jean, Sonia ^b,c   Gamache, Philippe ^c   Lebel, Stéfane ^d   Mac Way, Fabrice ^a,b   Biertho, Laurent ^d   Michou, Laëtitia ^a,b   Gagnon, Claudia ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARIATRIC SURGERY; CANADA; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; FEMALE; FEMUR FRACTURE; FOLLOW UP; FRACTURE; HIP FRACTURE; HUMAN; INCIDENCE; LIMB FRACTURE; MAJOR CLINICAL STUDY; MALE; OBESITY; PELVIS FRACTURE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SPINE FRACTURE; ADVERSE EFFECTS; COMPLICATION; FRACTURES, BONE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; PROCEDURES; QUEBEC;

ADULT; BARIATRIC SURGERY; CASE-CONTROL STUDIES; FEMALE; FRACTURES, BONE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; QUEBEC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84980349749     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i3794     Document Type: Article

References (62)

1. Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric Surgery Worldwide 2013. Obes Surg 2015;25:1822-32. doi:10.1007/s11695-015-1657-z.
2. Bruno C, Fulford AD, Potts JR, et al. Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. J Clin Endocrinol Metab 2010;95:159-66. doi:10.1210/jc.2009-0265.
3. Scibora LM. Skeletal effects of bariatric surgery: examining bone loss, potential mechanisms and clinical relevance. Diabetes Obes Metab 2014;16:1204-13. doi:10.1111/dom.12363.
4. Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 2004;89:1061-5. doi:10.1210/jc.2003-031756.
5. Yu EW, Bouxsein ML, Putman MS, et al. Two-year changes in bone density after Roux-en-Y gastric bypass surgery. J Clin Endocrinol Metab 2015;100:1452-9. doi:10.1210/jc.2014-4341.
6. Compston JE, Vedi S, Gianetta E, Watson G, Civalleri D, Scopinaro N. Bone histomorphometry and vitamin D status after biliopancreatic bypass for obesity. Gastroenterology 1984;87:350-6.
7. Parfitt AM, Pødenphant J, Villanueva AR, Frame B. Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study. Bone 1985;6:211-20. doi:10.1016/8756-3282(85)90003-1.
8. Marceau P, Biron S, Lebel S, et al. Does bone change after biliopancreatic diversion? J Gastrointest Surg 2002;6:690-8. doi:10.1016/S1091-255X(01)00086-5.
9. Nakamura KM, Haglind EG, Clowes JA, et al. Fracture risk following bariatric surgery: a population-based study. Osteoporos Int 2014;25:151-8. doi:10.1007/s00198-013-2463-x.
10. Lalmohamed A, de Vries F, Bazelier MT, et al. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ 2012;345:e5085. doi:10.1136/bmj.e5085.
11. Lu CW, Chang YK, Chang HH, et al. Fracture Risk After Bariatric Surgery: A 12-Year Nationwide Cohort Study. Medicine (Baltimore) 2015;94:e2087. doi:10.1097/MD.0000000000002087.
12. Corbeil P, Simoneau M, Rancourt D, Tremblay A, Teasdale N. Increased risk for falling associated with obesity: mathematical modeling of postural control. IEEE Trans Neural Syst Rehabil Eng 2001;9:126-36. doi:10.1109/7333.928572.
13. Epstein S, Defeudis G, Manfrini S, Napoli N, Pozzilli P. Scientific Committee of the First International Symposium on Diabetes and Bone. Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition. Osteoporos Int 2016;27:1931-51. doi:10.1007/s00198-015-3454-x.
14. Grethen E, McClintock R, Gupta CE, et al. Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab 2011;96:1320-6. doi:10.1210/jc.2010-2202.
15. Sánchez A, Rojas P, Basfi-Fer K, et al. Micronutrient Deficiencies in Morbidly Obese Women Prior to Bariatric Surgery. Obes Surg 2016;26:361-8. doi:10.1007/s11695-015-1773-9.
16. Muschitz C, Kocijan R, Marterer C, et al. Sclerostin levels and changes in bone metabolism after bariatric surgery. J Clin Endocrinol Metab 2015;100:891-901. doi:10.1210/jc.2014-3367.
17. Carrasco F, Ruz M, Rojas P, et al. Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg 2009;19:41-6. doi:10.1007/s11695-008-9638-0.
18. Folli F, Sabowitz BN, Schwesinger W, Fanti P, Guardado-Mendoza R, Muscogiuri G. Bariatric surgery and bone disease: from clinical perspective to molecular insights. Int J Obes (Lond) 2012;36:1373-9. doi:10.1038/ijo.2012.115.
19. Duan Y, De Luca V, Seeman E. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J Clin Endocrinol Metab 1999;84:718-22. doi:10.1210/jcem.84.2.5498.
20. Silverberg SJ, Shane E, de la Cruz L, et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 1989;4:283-91. doi:10.1002/jbmr.5650040302.
21. Fleischer J, Stein EM, Bessler M, et al. The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab 2008;93:3735-40. doi:10.1210/jc.2008-0481.
22. Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C. Endocrine Society. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010;95:4823-43. doi:10.1210/jc.2009-2128.
23. Johnson JM, Maher JW, Samuel I, Heitshusen D, Doherty C, Downs RW. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg 2005;9:1106-10, discussion 1110-1. doi:10.1016/j. gassur.2005.07.012.
24. Blais C, Sirois C, Rochette L, et al. Le Système Intégré de Surveillance des Maladies Chroniques du Québec (SISMACQ): une approche novatrice. Chronic Dis Inj Can 2014;34:247-56.
25. Pampalon R, Hamel D, Gamache P, Philibert MD, Raymond G, Simpson A. An area-based material and social deprivation index for public health in Québec and Canada. Can J Public Health 2012;103(Suppl 2):S17-22.
26. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9. doi:10.1097/01.mlr.0000182534.19832.83.
27. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000;53:1258-67. doi:10.1016/S0895-4356(00)00256-0.
28. Golob AL, Laya MB. Osteoporosis: screening, prevention, and management. Med Clin North Am 2015;99:587-606. doi:10.1016/j. mcna.2015.01.010.
29. Soltani S, Hunter GR, Kazemi A, Shab-Bidar S. The effects of weight loss approaches on bone mineral density in adults: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 2016; Epub ahead of print. doi:10.1007/s00198-016-3617-4.
30. Lebel S, Dion G, Marceau S, Biron S, Robert M, Biertho L. Clinical outcomes of duodenal switch with a 200-cm common channel: a matched, controlled trial. Surg Obes Relat Dis 2016;S1550-7289(16)00019-8; Epub ahead of print.
31. Robert M, Belanger P, Hould FS, Marceau S, Tchernof A, Biertho L. Should metabolic surgery be offered in morbidly obese patients with type I diabetes? Surg Obes Relat Dis 2015;11:798-805. doi:10.1016/j. soard.2014.12.016.
32. Baillot A, Mampuya WM, Dionne IJ, Comeau E, Méziat-Burdin A, Langlois MF. Impacts of Supervised Exercise Training in Addition to Interdisciplinary Lifestyle Management in Subjects Awaiting Bariatric Surgery: a Randomized Controlled Study. Obes Surg 2016; Epub ahead of print. doi:10.1007/s11695-016-2153-9.
33. Johansson H, Kanis JA, Odén A, et al. A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res 2014;29:223-33. doi:10.1002/jbmr.2017.
34. Sundh D, Rudäng R, Zoulakis M, Nilsson AG, Darelid A, Lorentzon M. A High Amount of Local Adipose Tissue Is Associated With High Cortical Porosity and Low Bone Material Strength in Older Women. J Bone Miner Res 2016;31:749-57. doi:10.1002/jbmr.2747.
35. Compston J. Obesity and bone. Curr Osteoporos Rep 2013;11:30-5. doi:10.1007/s11914-012-0127-y.
36. Compston JE, Flahive J, Hosmer DW, et al. GLOW Investigators. Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). J Bone Miner Res 2014;29:487-93. doi:10.1002/jbmr.2051.
37. Armstrong ME, Cairns BJ, Banks E, Green J, Reeves GK, Beral V. Million Women Study Collaborators. Different effects of age, adiposity and physical activity on the risk of ankle, wrist and hip fractures in postmenopausal women. Bone 2012;50:1394-400. doi:10.1016/j. bone.2012.03.014.
38. Prieto-Alhambra D, Premaor MO, Fina Avilés F, et al. The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women. J Bone Miner Res 2012;27:294-300. doi:10.1002/jbmr.1466.
39. Hage MP, El-Hajj Fuleihan G. Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass. Osteoporos Int 2014;25:423-39. doi:10.1007/s00198-013-2480-9.
40. Stein EM, Carrelli A, Young P, et al. Bariatric surgery results in cortical bone loss. J Clin Endocrinol Metab 2013;98:541-9. doi:10.1210/jc.2012-2394.
41. Berarducci A, Haines K, Murr MM. Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbid obesity. Appl Nurs Res 2009;22:35-41. doi:10.1016/j.apnr.2007.03.004.
42. Ikramuddin S, Billington CJ, Lee WJ, et al. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol 2015;3:413-22. doi:10.1016/S2213-8587(15)00089-3.
43. Chaston TB, Dixon JB, O'Brien PE. Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes (Lond) 2007;31:743-50.
44. Tarantino U, Piccirilli E, Fantini M, Baldi J, Gasbarra E, Bei R. Sarcopenia and fragility fractures: molecular and clinical evidence of the bone-muscle interaction. J Bone Joint Surg Am 2015;97:429-37. doi:10.2106/JBJS.N.00648.
45. Yu EW. Bone metabolism after bariatric surgery. J Bone Miner Res 2014;29:1507-18. doi:10.1002/jbmr.2226.
46. Muschitz C, Kocijan R, Haschka J, et al. The Impact of Vitamin D, Calcium, Protein Supplementation, and Physical Exercise on Bone Metabolism After Bariatric Surgery: The BABS Study. J Bone Miner Res 2016;31:672-82. doi:10.1002/jbmr.2707.
47. Karsenty G. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 2006;4:341-8. doi:10.1016/j.cmet.2006.10.008.
48. Abegg K, Gehring N, Wagner CA, et al. Roux-en-Y gastric bypass surgery reduces bone mineral density and induces metabolic acidosis in rats. Am J Physiol Regul Integr Comp Physiol 2013;305:R999-1009. doi:10.1152/ajpregu.00038.2013.
49. Canales BK, Schafer AL, Shoback DM, Carpenter TO. Gastric bypass in obese rats causes bone loss, vitamin D deficiency, metabolic acidosis, and elevated peptide YY. Surg Obes Relat Dis 2014;10:878-84. doi:10.1016/j.soard.2014.01.021.
50. Piché ME, Auclair A, Harvey J, Marceau S, Poirier P. How to choose and use bariatric surgery in 2015. Can J Cardiol 2015;31:153-66. doi:10.1016/j.cjca.2014.12.014.
51. Mechanick JI, Youdim A, Jones DB, et al. American Association of Clinical Endocrinologists Obesity Society American Society for Metabolic & Bariatric Surgery. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) 2013;21(Suppl 1):S1-27. doi:10.1002/oby.20461.
52. Modi AC, Zeller MH, Xanthakos SA, Jenkins TM, Inge TH. Adherence to vitamin supplementation following adolescent bariatric surgery. Obesity (Silver Spring) 2013;21:E190-5. doi:10.1002/oby.20031.
53. Cooper PL, Brearley LK, Jamieson AC, Ball MJ. Nutritional consequences of modified vertical gastroplasty in obese subjects. Int J Obes Relat Metab Disord 1999;23:382-8. doi:10.1038/sj.ijo.0800830.
54. Dunstan MJ, Molena EJ, Ratnasingham K, et al. Variations in oral vitamin and mineral supplementation following bariatric gastric bypass surgery: a national survey. Obes Surg 2015;25:648-55. doi:10.1007/s11695-014-1425-5.
55. Marceau P, Biron S, Marceau S, et al. Long-Term Metabolic Outcomes 5. to 20 Years After Biliopancreatic Diversion. Obes Surg 2015;25:1584-93. doi:10.1007/s11695-015-1599-5.
56. Kim J, Eisenberg D, Azagury D, Rogers A, Campos GM. American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefit after metabolic and bariatric surgery. Surg Obes Relat Dis 2016;12:453-9. doi:10.1016/j.soard.2015.11.021.
57. Sjöström L, Gummesson A, Sjöström CD, et al. Swedish Obese Subjects Study. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 2009;10:653-62. doi:10.1016/S1470-2045(09)70159-7.
58. Sjöström L, Narbro K, Sjöström CD, et al. Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007;357:741-52. doi:10.1056/NEJMoa 066254.
59. Courcoulas AP, Belle SH, Neiberg RH, et al. Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial. JAMA Surg 2015;150:931-40. doi:10.1001/jamasurg.2015.1534.
60. Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia 2016;59:945-53. doi:10.1007/s00125-016-3903-x.
61. Sjöström CD, Lissner L, Wedel H, Sjöström L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999;7:477-84. doi:10.1002/j.1550-8528.1999. tb00436.x.
62. Martin BJ, Chen G, Graham M, Quan H. Coding of obesity in administrative hospital discharge abstract data: accuracy and impact for future research studies. BMC Health Serv Res 2014;14:70. doi:10.1186/1472-6963-14-70.